DEA Takes On Marijuana Regulatory Role Under Trump's Rescheduling Initiative

The Trump administration's federal rescheduling of marijuana is shifting regulatory authority from state agencies to the DEA, fundamentally changing how cannabis businesses operate. For years, marijuana operators primarily answered to state regulators, but this new federal policy development introduces comprehensive federal oversight and compliance requirements. Industry experts note that achieving federal legitimacy comes with increased regulation and operational scrutiny. This regulatory shift has significant implications for medical marijuana programs, patient access, and the legal cannabis market across all states, including Puerto Rico. Patients and businesses must understand how these new federal frameworks may impact medical cannabis availability and quality standards.

Originally published on
Marijuana Moment
By Marijuana Moment
Read full article(opens in new tab)Fetched: September 16, 2026 at 10:02 AM



